March 11, 2010 - A new PET/CT (postitron emission tomography/computed tomography) system provides imaging for both the clinical areas of both radiology and oncology.

March 11, 2010 – The FDA cleared a new family of introducers which offer features intended to minimize trauma to the artery and set the stage for closure using a closure device. The products also recently gained European CE mark approval.

Vascular Solutions offers a variety of hemostasis products used to stop bleeding. D-Stat products rely on biologically active components to induce bleeding cessation.The products use thrombin, a natural component of the clotting cascade. Thrombin cleaves fibrinogen to fibrin, enhancing the body's own ability to produce clot.

D-Stat Dry


March 12, 2010 – In partnership with the American College of Cardiology (ACC), Philips is spotlighting the growing need for hybrid cath labs with a specialty exhibit during ACC 2010 March 14-16 in Atlanta.

Vytorin is a medicine used to lower levels of total cholesterol, LDL (bad) cholesterol, and fatty substances called triglycerides in the blood. The prescription-only medication is intended for patients who cannot control their cholesterol levels by diet and exercise alone.

March 10, 2010 - To help clinicians communicate about radiation dose exposure during radiological procedures, a new dose-saving solution for use in interventional radiology procedures is now available.

Unlike the most common cholesterol-lowering medicines, statins, that work mainly in the liver, a new drug attempts to fight cholesterol by focusing on the digestive tract.

An FDA-approved, cholesterol-lowering medication has been proven to significantly reduce the risk of heart attack, stroke, certain kinds of heart surgeries and chest pain.


Lowering radiation dose and improving navigation abilities of angiography systems have been among the top priorities of manufactures over the past year. Another big trend is integration of angiography systems in hybrid cath lab/operating rooms (ORs) as collaboration between surgeons and interventionalists improves with increasingly less-invasive procedures.


Editor’s note: Jerome Granato, M.D., is the medical director of the coronary care unit at Allegheny General Hospital in Pittsburgh, Pa. His facility started looking at ways to cut its nosocomial infection rates several years ago. This issue has a broader importance today, with CMS now cutting reimbursements for hospital-acquired infections and other “never events.”
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now